June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
A New Model for Glaucoma Filtering Surgery in Mice
Author Affiliations & Notes
  • Jan Tode
    Ophthalmology, Medizinische Hochschule Hannover, Hannover, Niedersachsen, Germany
  • Maximilian Binter
    Ophthalmology, Medizinische Hochschule Hannover, Hannover, Niedersachsen, Germany
  • Esther Molinski
    Ophthalmology, Medizinische Hochschule Hannover, Hannover, Niedersachsen, Germany
  • Stephanie Hempel
    Ophthalmology, Medizinische Hochschule Hannover, Hannover, Niedersachsen, Germany
  • Miriam Heider
    Animal Research, Medizinische Hochschule Hannover, Hannover, Niedersachsen, Germany
  • Carsten Framme
    Ophthalmology, Medizinische Hochschule Hannover, Hannover, Niedersachsen, Germany
  • Heiko Fuchs
    Ophthalmology, Medizinische Hochschule Hannover, Hannover, Niedersachsen, Germany
  • Philipp Luedtke
    Ophthalmology, Medizinische Hochschule Hannover, Hannover, Niedersachsen, Germany
  • Footnotes
    Commercial Relationships   Jan Tode Novartis, Code R (Recipient), Bayer, Code R (Recipient), Atheneum Consulting, Code R (Recipient); Maximilian Binter None; Esther Molinski None; Stephanie Hempel None; Miriam Heider None; Carsten Framme Bayer, Code R (Recipient), Novartis, Code R (Recipient), MedUpdate, Code R (Recipient); Heiko Fuchs None; Philipp Luedtke None
  • Footnotes
    Support  Hannover Medical School Glaucoma Fund
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 441. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jan Tode, Maximilian Binter, Esther Molinski, Stephanie Hempel, Miriam Heider, Carsten Framme, Heiko Fuchs, Philipp Luedtke; A New Model for Glaucoma Filtering Surgery in Mice. Invest. Ophthalmol. Vis. Sci. 2022;63(7):441.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Fibrosis is a glaucoma filtration surgery (GFS) problem that often demands reoperation. At present, different antifibrotic drugs are used to inhibit fibrosis with unsatisfactory results. Only a few GFS mouse models for drug research exist. These are difficult to perform and complicated by the big murine lens, which can easily be damaged while penetrating the anterior chamber. We designed the first GFS mouse model without anterior chamber penetration, leaving the lens safely untouched.

Methods : Baseline intraocular pressure (IOP) was measured under inhalation anesthesia. Then, surgery was performed in six C57BL/6J mice under general anesthesia. A 27G needle was inserted into the conjunctiva and slid forward subconjunctivally close to the limbus. The sclera was penetrated, and a fistula was created between the posterior chamber and subconjunctival space. Afterwards, clinical examination and IOP-measurement under inhalation anesthesia followed every two days for two weeks.

Results : Postoperatively, a filtering bleb was seen in every mouse (n=6). Mean IOP decreased from 14.2 mmHg (±3.0 SD) at baseline to 8.33 mmHg (±0.9) on day two after surgery. The conjunctiva was elevated until day two in every mouse. Between days four and eight, pigment and stronger conjunctival injection were seen at the fistula, as well as a significant IOP rise. From day eight onwards, IOP stayed at baseline values; the GFS bleb was flat again.
Mean IOP values (±SD) during follow-ups were: 11.5 mmHg (± 3.7) at day 4, 13.0 mmHg (±2.7) at day 6, 9.6 mmHg (±2.0) at day 8, 13.2 mmHg (±1.2) at day 10, 14.4 mmHg (±0.2) at day 12, and 15.2 mmHg (±2.8) at day 14. No infectious complications were seen.

Conclusions : We developed a new, inexpensive, easy to perform, reproducible GFS mouse model, which can be used for fibrosis research or antifibrotic drug screening in vivo. It works without penetration of the anterior chamber, leaving the large murine lens untouched and thereby minimizing complications.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×